Kee Song Bio Technology: New KSA Loans Granted to KSR Exceeding NT$10 Million or 2% of Company Net Worth on Latest Financial Statements







Close

Provided by: Kee Song Bio-Technology Holdings Limited

SEQ_NO

1

announcement date

2022/02/07

Announcement time

16:23:05

Topic

 KSA new loans extended to KSR exceeding
NT$10 million or 2% of the Company's net worth on the
latest financial statements

Date of events

2022/01/10

What item it responds to

paragraph 23

Declaration

1.Date of occurrence of the event:2022/01/10
2.Funding recipient (1)Name(2)Relationship with lender
(3)Lending limit (thousand NTD)(4)Starting outstanding
balance (thousand NTD)(5)New loan (thousand NTD)(6)Is
it part of a scheduled allocation or revolving limit
for the same recipient that the chairman is authorized
by the board of directors to allocate(7)Outstanding
balance (thousand NTD) up to the date of occurrence
(8)Reason for new loan (thousand NTD):
(1)Name:Kee Song Realty (M) Sdn Bhd
(2)Relationship with lender:lending funds between subsidiaries of the Company
(3)Lending limit (thousand NTD):74104
(4)Starting outstanding balance (thousand NTD):8644
(5)New loan (thousand NTD):43887
(6)Is it part of a scheduled allocation or revolving limit for the same
recipient that the chairman is authorized by the board of directors to
allocate:No
(7)Outstanding balance (thousand NTD) up to the date of occurrence:52531
(8)Reason for new loan (thousand NTD):working capital needs
3.For collaterals provided by the loan recipient, the
(1)Content(2)Value (thousand NTD):(1)Content:None
(2)Value (thousand NTD):0
4.For the latest financial reports of the loan recipient, the
(1)Capital (thousand NTD)(2)Cumulative gains/losses
(thousand NTD):(1)Capital (thousand NTD):7500
(2)Cumulative gains/losses (thousand NTD):-3
5.Method of calculation of interest:bank interest rates
6.For repayment, the(1)Condition(2)Date:
(1)Condition:5 years
(2)Date:By January 9, 2027
7.The amount of monetary loans extended to others as
of the date of occurrence (thousand NTD):163564
8.The total amount of monetary loans extended to others
as a percentage of the public company��s net worth on
the latest financial statements as of the date of
occurrence:31.27
9.Sources of funds for the company to extend monetary
loans to others:Self funding
10.Any other matters that need to be specified:None

Warning

Kee Song Bio-Technology Holdings Ltd. published this content on February 07, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unmodified, on February 07, 2022 08:37:05 UTC.

Public now 2022

All news from KEE SONG BIO-TECHNOLOGY HOLDINGS LIMITED

Sales 2020 2,545 million
91.3M
91.3M
Net result 2020 -15.8M
-0.57M
-0.57M
Net debt 2020 1,187 million
42.6 million
42.6 million
2020 PER ratio -39.2x
2020 performance
Capitalization 711M
25.5 million
25.5 million
EV / Sales 2019 0.67x
EV / Sales 2020 0.71x
# of employees
Floating 28.3%

Chart KEE SONG BIO-TECHNOLOGY HOLDINGS LIMITED


Duration :

Period :




Kee Song Bio-Technology Holdings Limited Technical Analysis Chart |  MarketScreener



Evolution of the income statement


Comments are closed.